Cargando…

Correction: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells

Detalles Bibliográficos
Autores principales:	Siebenkäs, Cornelia, Chiappinelli, Katherine B., Guzzetta, Angela A., Sharma, Anup, Jeschke, Jana, Vatapalli, Rajita, Baylin, Stephen B., Ahuja, Nita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728177/ https://www.ncbi.nlm.nih.gov/pubmed/33301506 http://dx.doi.org/10.1371/journal.pone.0243944

Ejemplares similares

Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
por: Siebenkäs, Cornelia, et al.
Publicado: (2017)

Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
por: Sharma, Anup, et al.
Publicado: (2017)

Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
por: Sharma, Anup, et al.
Publicado: (2020)

Inhibiting DNA methylation improves antitumor immunity in ovarian cancer
por: Chiappinelli, Katherine B., et al.
Publicado: (2022)

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
por: Li, Huili, et al.
Publicado: (2014)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
por: Vlasenkova, Ramilia, et al.
Publicado: (2023)

Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer
por: Khan, Ghazala, et al.
Publicado: (2015)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

The cancer testis antigen TDRD1 regulates prostate cancer proliferation by associating with snRNP biogenesis machinery
por: Feng, Qin, et al.
Publicado: (2023)

Engineering Cancer/Testis Antigens With Reversible S-Cationization to Evaluate Antigen Spreading
por: Miyamoto, Ai, et al.
Publicado: (2022)

Inducible expression of antigen processing and antigen presentation molecules and cancer testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2015)

Cancer‐testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis
por: Lin, Lina, et al.
Publicado: (2021)

Cancer testis antigen XAGE-1 is a promising marker for the diagnosis and treatment of ovarian cancer
por: Jumaa, Maysaa Ghazi, et al.
Publicado: (2021)

Targeting cancer testis antigens in synovial sarcoma
por: Mitchell, Geoffrey, et al.
Publicado: (2021)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
por: Nin, Dawn Sijin, et al.
Publicado: (2023)

Cancer immune escape: the role of antigen presentation machinery
por: Kallingal, Anoop, et al.
Publicado: (2023)

Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer
por: Chiriva-Internati, Maurizio, et al.
Publicado: (2010)

Pattern of cancer/testis antigen expression in lung cancer patients
por: KIM, YEONG-DAE, et al.
Publicado: (2012)

Cancer testis antigens: A new paradigm for cancer therapy
por: Suri, Anil, et al.
Publicado: (2012)

Cancer/testis antigens (CTAs) expression in resected lung cancer
por: Jin, Shi, et al.
Publicado: (2018)

Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
por: Zhang, Yujie, et al.
Publicado: (2019)

Inducible expression of cancer-testis antigens in human prostate cancer
por: Heninger, Erika, et al.
Publicado: (2016)

Cancer-testis antigen expression and immunogenicity in AL amyloidosis
por: Rosenzweig, M A, et al.
Publicado: (2012)

Immunotherapy in Multiple Myeloma Using Cancer-Testis Antigens
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2015)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
por: Kim, Ye-Rin, et al.
Publicado: (2021)

An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen
por: Cheng, Peter, et al.
Publicado: (2023)

Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers
por: Shida, Akiko, et al.
Publicado: (2020)

Cancer/testis antigens and obligate participation in multiple hallmarks of cancer: an update
por: Mooney, Steven M, et al.
Publicado: (2016)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects()
por: Wei, Xiao, et al.
Publicado: (2019)

CAR T-Cell Cancer Therapy Targeting Surface Cancer/Testis Antigens
por: Jakobsen, Mie K., et al.
Publicado: (2020)

The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
por: Xu, Yichi, et al.
Publicado: (2020)

Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential
por: Naik, Adviti, et al.
Publicado: (2021)

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers
por: Ai, Huihan, et al.
Publicado: (2023)

Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC
por: Glazer, Chad A., et al.
Publicado: (2009)

The Novelty of Human Cancer/Testis Antigen Encoding Genes in Evolution
por: Dobrynin, Pavel, et al.
Publicado: (2013)

Expression of Cancer/Testis Antigens is Correlated with Improved Survival in Glioblastoma
por: Freitas, Marcelo Roberto Pereira, et al.
Publicado: (2013)

Cancer testis antigens and genomic instability: More than immunology(,)
por: Jay, Ash, et al.
Publicado: (2021)

Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
por: Shim, Kyeonghee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mu5td8ejhn5dnp04j0dcsgbkcv